Fatty Liver Disease in Nordic Countries
ConditionNon-Alcoholic Fatty Liver Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCopenhagen University Hospital, Hvidovre
About this trial
A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Non-alcoholic fatty liver disease and
Healthy volunteers
Disqualifiers
Other liver diseases than non-alcoholic fatty liver disease
Lack of informed consent
Trial population
The investigators plan to include patients with suspected or verified non-alcoholic fatty liver disease
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Proteomics
Diagnostic testMass-spectometry proteomics
Transcriptomics
Diagnostic testNext generation sequencing
Genomics
GeneticTargeted genetics
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Fibrosis
Number of participants with fibrosis proression
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov